Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 525 of 715 entries
View as:

Safety, Tolerability, Effect of Vildagliptin and How the Body Changes the Blood Level of Vildagliptin in Healthy Chinese Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00419887 Org: User:
Start: 09/30/06 End: - Due: -

Pharmacokinetics (PK) and Metabolism of FTY720 in Patients With Severe Renal Impairment and Healthy Matched Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT00731523 Org: User:
Start: 07/31/08 End: - Due: -

Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Renal Transplant Patients

Phase: N/A Priority: Normal
NCT ID: NCT00239083 Org: User:
Start: 01/31/05 End: 08/31/06 Due: 08/31/07

Safety and Efficacy of Lumiracoxib Versus Naproxen in Acute Musculoskeletal Pain

Phase: N/A Priority: Normal
NCT ID: NCT00170898 Org: User:
Start: 11/30/04 End: - Due: -

Extension Study of the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT00241059 Org: User:
Start: 08/31/02 End: 01/31/05 Due: 01/31/06

A Safety and Efficacy Trial of the Combination of Aliskiren / Hydrochlorothiazide (HCTZ)(300/12.5 mg and 300/25 mg) Compared to Aliskiren 300 mg in Hypertensive Patients

Phase: N/A Priority: Normal
NCT ID: NCT00386139 Org: User:
Start: 09/30/06 End: 07/31/07 Due: 07/31/08

Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization

Phase: N/A Priority: Normal
NCT ID: NCT00436553 Org: User:
Start: 02/28/07 End: 10/31/09 Due: 10/31/10

Preference of Tegaserod vs. PEG 3350 in Patients With Constipation

Phase: N/A Priority: Normal
NCT ID: NCT00171522 Org: User:
Start: 05/31/05 End: 09/30/05 Due: 09/30/06

Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00138515 Org: User:
Start: 11/30/04 End: 05/31/06 Due: 05/31/07

Effect of Vildagliptin on Fat and Muscle Metabolism in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00380445 Org: User:
Start: 01/31/06 End: 04/30/07 Due: 04/30/08

Efficacy and Safety of Oral Famciclovir in Patients With Active Recurrent Genital Herpes

Phase: N/A Priority: Normal
NCT ID: NCT00171990 Org: User:
Start: 01/31/03 End: 02/28/06 Due: 02/28/07

Efficacy and Tolerability of an Aliskiren-based Treatment Algorithm in Patients With Mild to Moderate Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00765947 Org: User:
Start: 09/30/08 End: 08/31/09 Due: 08/31/10

Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00703703 Org: User:
Start: 05/31/08 End: 10/31/08 Due: 10/31/09

Assessment of Efficacy and Safety of Tegaserod in Male Patients With Chronic Constipation.

Phase: N/A Priority: Normal
NCT ID: NCT00141089 Org: User:
Start: 03/31/04 End: 02/28/05 Due: 02/28/06

Tolerability, Safety and Efficacy of RKI983 Eye Drops in Subjects With Primary Open Angle Glaucoma and Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00515424 Org: User:
Start: 07/31/07 End: - Due: -

A Phase 4, Placebo-Controlled, Randomized Study to Evaluate the Immunogenicity and Safety of HPV and Tdap When Administered With MenACWY in Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT01424644 Org: User:
Start: 09/30/11 End: 12/31/12 Due: 12/31/13

A Comparison of Certoparin and Unfractionated Heparin in the Prevention of Thromboembolic Events in Acutely Ill Medical Patients

Phase: N/A Priority: Normal
NCT ID: NCT00451412 Org: User:
Start: 01/31/07 End: 06/30/09 Due: 06/30/10

A Clinical Study to Evaluate Safety & Efficacy of the Combination of Aliskiren, Valsartan & Hydrochlorothiazide in Diabetic Hypertensive Nonresponder Patients

Phase: N/A Priority: Normal
NCT ID: NCT00219102 Org: User:
Start: 06/30/05 End: 05/31/07 Due: 05/31/08

Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A302

Phase: N/A Priority: Normal
NCT ID: NCT00149864 Org: User:
Start: 02/29/00 End: 12/31/03 Due: 12/31/04

Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2007/2008

Phase: N/A Priority: Normal
NCT ID: NCT00498303 Org: User:
Start: 06/30/07 End: - Due: -

Efficacy and Safety of Pimecrolimus Cream 1% in Patients (2 to 11 Years Old) With Mild to Moderate Facial Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT00130364 Org: User:
Start: 08/31/05 End: 08/31/06 Due: 08/31/07

Safety, Pharmacodynamic and Pharmacokinetic Effects of QAX576 in Healthy Volunteers.

Phase: N/A Priority: Normal
NCT ID: NCT00417196 Org: User:
Start: 12/31/06 End: 08/31/07 Due: 08/31/08

The Effect of Indacaterol on Exercise Endurance in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT00620022 Org: User:
Start: 04/30/08 End: 01/31/09 Due: 01/31/10

Safety and Efficacy of Galvus as add-on Therapy to Metformin Plus Glimepiride

Phase: N/A Priority: Normal
NCT ID: NCT01233622 Org: User:
Start: 10/31/10 End: 11/30/11 Due: 11/30/12

Pharmacokinetic and Pharmacodynamic Profiles of Aliskiren in Japanese Patients With Mild to Moderate Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00424541 Org: User:
Start: 01/31/07 End: 08/31/07 Due: 08/31/08